Fonar Corporation (NASDAQ:FONR - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $14.29 and traded as high as $16.18. Fonar shares last traded at $16.00, with a volume of 50,981 shares changing hands.
Wall Street Analyst Weigh In
Separately, Wall Street Zen downgraded Fonar from a "strong-buy" rating to a "buy" rating in a research report on Friday.
Read Our Latest Research Report on FONR
Fonar Stock Performance
The firm has a fifty day moving average price of $14.64 and a 200 day moving average price of $14.29. The stock has a market cap of $98.95 million, a PE ratio of 12.77 and a beta of 1.00.
Fonar (NASDAQ:FONR - Get Free Report) last released its earnings results on Thursday, May 15th. The medical equipment provider reported $0.37 earnings per share (EPS) for the quarter. Fonar had a return on equity of 5.31% and a net margin of 8.19%.
Institutional Investors Weigh In On Fonar
A number of institutional investors have recently modified their holdings of FONR. Bridgeway Capital Management LLC boosted its holdings in Fonar by 1.2% in the 4th quarter. Bridgeway Capital Management LLC now owns 80,035 shares of the medical equipment provider's stock worth $1,212,000 after buying an additional 945 shares during the last quarter. Empowered Funds LLC boosted its holdings in Fonar by 7.7% in the 1st quarter. Empowered Funds LLC now owns 21,139 shares of the medical equipment provider's stock worth $296,000 after buying an additional 1,504 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Fonar by 0.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 376,678 shares of the medical equipment provider's stock worth $5,703,000 after buying an additional 2,149 shares during the last quarter. Money Concepts Capital Corp boosted its holdings in shares of Fonar by 1.2% during the 1st quarter. Money Concepts Capital Corp now owns 406,296 shares of the medical equipment provider's stock worth $5,692,000 after purchasing an additional 4,719 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC boosted its holdings in shares of Fonar by 16.5% during the 1st quarter. Linden Thomas Advisory Services LLC now owns 34,054 shares of the medical equipment provider's stock worth $477,000 after purchasing an additional 4,818 shares during the last quarter. 50.64% of the stock is currently owned by institutional investors and hedge funds.
About Fonar
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
See Also
Before you consider Fonar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fonar wasn't on the list.
While Fonar currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
